Forget the old way! The FDA is tapping into predictive AI to radically change how drugs get appro...

A fascinating look at the cutting edge of pharmaceutical regulation. The discussion reveals how the Food and Drug Administration is exploring a seismic shift in clinical trial architecture. Instead of rigid, sequential stages, advanced predictive analytics—specifically Bayesian modeling—are being examined to streamline the process. Imagine condensing phases one and two, or two and three, based on superior predictive pre-screening. This powerful statistical tool allows for a more predictive assessment of trial success, potentially accelerating the entire timeline for bringing new treatments to the public.
#FDA #AIinHealthcare #DrugDevelopment #ClinicalTrials #BayesianModeling #PredictiveAnalytics #MedicalInnovation

Видео Forget the old way! The FDA is tapping into predictive AI to radically change how drugs get appro... канала Dan Sfera